Atrial fibrillation and chronic kidney disease: focus on rivaroxaban.

about

Nonvitamin K antagonist oral anticoagulant use in patients with renal impairment.Use of direct oral anticoagulants in patients with nonvalvular atrial fibrillation according to clinical profile.Rivaroxaban in patients with atrial fibrillation: from ROCKET AF to everyday practice.

P2860

Q38708508-47F0AA75-DF2D-4538-8F43-1C38088C59F1 Q38812464-D9D883A1-95F1-47B8-A840-CAAD57C78F45 Q39187952-E7048E47-0620-4756-982A-17ADFC473C27

P2860

Atrial fibrillation and chronic kidney disease: focus on rivaroxaban.

Item

http://www.wikidata.org/entity/Q41341319

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Atrial fibrillation and chronic kidney disease: focus on rivaroxaban.

@en

type

Item

label

Atrial fibrillation and chronic kidney disease: focus on rivaroxaban.

@en

prefLabel

Atrial fibrillation and chronic kidney disease: focus on rivaroxaban.

@en

P1476

Atrial fibrillation and chronic kidney disease: focus on rivaroxaban.

@en

P2093

José Luis Górriz

http://www.w3.org/2001/XMLSchema#string

Vivencio Barrios

http://www.w3.org/2001/XMLSchema#string

P2860

Systematic review and meta-analysis of incidence, prevalence and outcomes of atrial fibrillation in patients on dialysis

Anticoagulation for atrial fibrillation in patients on dialysis: are the benefits worth the risks?

Vitamin k dependent proteins and the role of vitamin k2 in the modulation of vascular calcification: a review.

Calciphylaxis: risk factors, diagnosis, and treatment

Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction

Dabigatran versus warfarin in patients with atrial fibrillation

Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization

Epidemiology of atrial fibrillation: European perspective

Prevalence of chronic kidney disease in the United States

Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study

P304

651-664

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/CER.15.44

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-09-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

282047255

http://www.w3.org/2001/XMLSchema#string

P698

26388302

http://www.w3.org/2001/XMLSchema#string

Atrial fibrillation and chronic kidney disease: focus on rivaroxaban.

about

P2860

P2860

Atrial fibrillation and chronic kidney disease: focus on rivaroxaban.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698